Potential of mesoporous silica nanoparticles for the delivery of anticancer bioactive compounds

The potential for dosing anticancer target molecules of silica nanoparticles with ordered mesoporosity (SiMONPs), 28 nm in diameter and surface area of 706 m2/g, was evaluated by the loading and release of carvacrol, chloroquine, and rhodamine-B. The ligand-protein interaction (BRAF oncogene) was determined by docking. The fine structure of the SiMONPs with nanometric porosity allowed a slow and progressive release according to the passive diffusion mechanism. The most favorable anticancer interaction was displayed by carvacrol with a ligand efficiency value of -6.7 kcal/mol. At the same time, chloroquine and rhodamine-B had values of -5.0 kcal/mol and -3.4 kcal/mol, severally. The target displayed a "preference" to interact first with the SiMONPs rather than with carvacrol. The material could be dosed at 0.0009 mg/h for a week under PBS medium conditions, so the material resulted suitable for dosing and controlling the growth of skin cancer cells.